![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Feedback Plc | LSE:FDBK | London | Ordinary Share | GB00BJN59X09 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 60.50 | 60.00 | 61.00 | 60.50 | 60.50 | 60.50 | 14,770 | 07:44:37 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electronic Computers | 1.03M | -2.92M | -0.2188 | -2.77 | 8.07M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/9/2019 03:57 | Hi Guy,s In all honesty what we discuss on here whether in a negative or positive fashion is totally irreverent to the direction of the share price the market will dictate that so no point in beating about the bush let,s stick to the facts and a grip on reality otherwise our posts will not have any credibility A lot in the know have realized a long time ago that Feedback plc is an out an out DOG ( based on past performance ) do I take a joy in writing that NO DIF !! As I am one of those Muppet,s who believed in the TexRAD story ( having been informed from a " cant say reliable " knowledgeable source the tech was worth a lot of money to the likes of Siemens,GE etc ) So I HODL despite Uncle Trev posting the reality and we choose to ignore, C,Mon If TexRAD was/ is worth anything like its cracked up to be then it was 3 or 4 years ago ,Tech develops so fast its probably obsolete TBO, If Cadran waa such a versatile multi use tech it would be in a few more outlets that Papworth, If Bleepa is the " Tool everyone wants and the future of NHS communication" dont you think someone JUST ONE would have endorsed the product or even agreed to a Pilot programme , So all 3 Tech,s they have on sale do not generate sales because nobody wants them !! FACT Despite an Army of sales people since November 2018 !!All generating expense accounts ,salaries company cars as are the BOD who have managed to whip up over 100% dilution whilst hammering down the share price to all time Low,s ,Instigating placing after placing awarding themselves options for achieving absolutely Sweet FA ! I so wish I could post massive multi bagger posts based on the growth of TexRAD Lung and uhh all the other Apps that were in the pipe line , Brain,Kidney,Liver, Prostrate etc etc Or even the the contracts or Pilot programmers they have announced since Bleepa RNS in mid July ,, Alas ! Its the same OLd Pishhhh coming out of Bourn as in - " Calm before the storm " nonsense , We want adoption and sales figures not smoke an mirrors innuendos, Shareholders need proof as does the market Again I say ,, Its a travesty we are not anywhere near the 5 p or even 10p mark ( and we would have been if the those same plonka,s had not made a total hash of the placing ,There were so many options to take that would have stimulated the share price and taken advantage of that momentum gained to propel the company and its fortunes to a much higher level , Alas ! Same Old , So if your expecting something anywhere near Shareholder Value , you will have a long wait FACT So NHS Directors scrutinizing the caliber of Feedback management and past performance are going to take the same view ( as in TexRAD / Cardran ) as the market and its like - Mhh nice very pioneering tech and a compelling software but the people behind it !! Sorry pass on that one | ![]() botak54 | |
21/9/2019 20:00 | bob, Texrad will be a winner, for sure but the likes of Siemens, Alliance, GE are holding back, waiting to see who moves first, can they pick it up for a song? If Bleepa looks like being a commercial succes and sends the share price higher then expect one of the above to make a move. Here's hoping and GLA. | ![]() ducatiman | |
21/9/2019 19:15 | Yes duc, there is no doubting the products or technology so if FDBK are unable to commercialise the benefits then sell the IP or the Company and let shareholders have some benefit. I don’t think it will come to that, but you cannot ignore Botak’s thoughts either. Next 6 months will decide the future imo. | ![]() bobd29 | |
21/9/2019 18:56 | No new fundraise as that would be game over, ducati is correct, so many placings but no new sales, beggars belief. If bleepa doesn't take off I would be prepared to sue the directors for mis-information, or better still, all investors do a collective litigation against them if they do not pull this off | sonie01 | |
21/9/2019 18:48 | bob, 2 years ago Texrad lung achieved the CE mark which we believed would open doors to uptake in a clinical setting. Placing to acquire a sales team to sell it, Placing to achieve FDA approval, placing to develop Bleepa. Sales? Therein lies the issue. I do believe the products are superb but if nobody wants to buy them!? Hopefully over the coming weeks/months we will get the news that there is demand for the products, that would be a huge turning point for this extremely clever technology. | ![]() ducatiman | |
21/9/2019 06:48 | 12 months ! Your aving a Giraffe duc, If no forecast to generate revenues by Q1 20 its game over / Goodnight Eillen , No money left and an share price of 0.3 Only alternative would be death spiral , Who would still be hanging around by then Oh,,Yes ,, of course TC & Cranston would !! + maybe a few others posting they gonna top up if it falls any lower !!!!!! Coz they have discovered a new tech that bolts on to TexRAD to enhance PET scans and is the tool everyone wants coz its the future of NHS Imaging ZZZzzzzzzzz | ![]() botak54 | |
21/9/2019 00:21 | They know they won’t get another fundraise away duc, so yes I also expect news soon along with increasing revenue generation. That should underpin the sp, a lot of us will feel more comfortable when it’s closer to 2p than 1p...quite laughable considering where we were 2years ago! | ![]() bobd29 | |
20/9/2019 21:49 | bob, with current cashburn they need to pull a rabbit out of the hat within 12 months or it is curtains. I am sure the BOD is aware and I expect a move towards meaningful revenue soon. | ![]() ducatiman | |
20/9/2019 19:54 | Agree sonie some news would be good but it has only been two weeks since expo, give it another couple of weeks and hopefully we will then get a clear roadmap for Bleepa integration as well as commercialisation of TexRAD. The share price will then respond and long suffering shareholders can then breath a sigh of relief. If BODs read this bb, let us hope they take notice. | ![]() bobd29 | |
20/9/2019 18:04 | They normally say no news is good news, but not here!! Give us some news feedback! | sonie01 | |
19/9/2019 16:46 | Nah bit of a push on twitter...looks like some of those are buys to me. IMO | ![]() hazl | |
19/9/2019 16:30 | sub 1p - ohh yes perlease ..... 0.75 is my favourite decimal ..... | ![]() georgesorearse | |
19/9/2019 14:12 | Same story again with this one? I hope not | sonie01 | |
19/9/2019 13:26 | Looks like 1.09 offer. Could go sub 1 without news. | ![]() ducatiman | |
19/9/2019 09:23 | It’s a waiting game sonie as we look to TO to start spinning his web. I realise contract negotiations with public bodies can take a long time but we could do with an update ASAP. The expected TexRAD update should be here soon,then maybe we can see the share price react positively. | ![]() bobd29 | |
19/9/2019 09:13 | Newtothis post something that is relevant and not kid news | sonie01 | |
18/9/2019 18:51 | All quiet again | sonie01 | |
18/9/2019 15:20 | Lol. What a crazy fool! | tech_ip | |
18/9/2019 09:08 | Bleepa ? @BleepaMe 6 minutes ago Today 09:07 | ![]() newtothisgame3 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions